—

GILEAD SCIENCES, INC.

Q1 2026 13F Holdings

  • Location
    foster city, CA
  • Num holdings

    6

  • Value ($000)

    $2,117,785

  • Date Filed
    05/08/2026
  • Form type
    13F-HR
  • CIK
    0000882095
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ACLX

Arcellx Inc

COM
03940C100
$771.68M
36 %

6,720,803

R
RCUS

Arcus Biosciences Inc

COM
03969F109
$678.77M
32 %

31,424,760

G
GLPG

Galapagos NV

SPON ADR
36315X101
$501.22M
24 %

16,707,477

A
ASMB

Assembly Biosciences Inc

COM NEW
045396207
$125.02M
6 %

4,505,391

K
KYTX

Kyverna Therapeutics Inc

COM
501976104
$35.61M
2 %

4,126,119

X
XLO

Xilio Therapeutics Inc

COM
98422T100
$5.47M
0 %

650,389

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6